Programs & Initiatives in Communities
Opioid Abuse Community Prevention Pilot Projects
The Opioid Abuse Community Prevention Pilot Projects will be funded through a competitive process in geographic areas throughout the state based on the most recently available data on opioid overdose and abuse rates. The grants aim to reduce opioid abuse through the use of controlled substance care teams and community-wide coordination of abuse-prevention initiatives.
The Opioid Abuse Community Prevention Pilot Projects must:
- Be designed to reduce emergency room and other health care provider visits resulting from opioid use or abuse, and reduce rates of opioid addiction in the community;
- Establish multidisciplinary controlled substance care teams, that may consist of physicians, pharmacists, social workers, nurse care coordinators, and mental health professionals;
- Deliver health care services and care coordination, through controlled substance care teams, to reduce the inappropriate use of opioids by patients and rates of opioid addiction;
- Address any unmet social service needs that create barriers to managing pain effectively and obtaining optimal health outcomes;
- Provide prescriber and dispenser education and assistance to reduce the inappropriate prescribing and dispensing of opioids;
- Promote the adoption of best practices related to opioid disposal and reducing opportunities for illegal access to opioids; and
- Engage partners outside of the health care system, including schools, law enforcement, and social services, to address root causes of opioid abuse and addiction at the community level.
Request for proposals: Pilot Prevention Project Grants
Eligible applicants include tribal governments, local units of government, health care providers, health plan companies or other entities.
Mandatory requirements: Each pilot project must address each of the seven goals described above. Each pilot program must also:
- Name a physician/prescriber as the program champion for the organization; this champion will also serve as the subject matter expert for prescribers;
- Agree for at least one prescriber (either with or in collaboration with the organization) to become licensed by the Drug Enforcement Agency (DEA) to prescribe Suboxone and learn to implement a medication assisted treatment (MAT) program;
- Dedicate the time and resources necessary to support an active multi-disciplinary care team;
- Seek medical home certification (if not already so certified);
- Collect measurement and outcome data including:
- A registry or panel of patients with chronic opioid prescriptions;
- Baseline and tapers;
- Payor mix data;
- Referrals to community resources and to behavioral/mental health treatment facilities;
- Community engagement and participation;
- Opioid prescriptions filled from at least one local pharmacy;
- Heroin and prescription drug overdoses (fatal and nonfatal) in county/service area; and
- Minutes from meetings of a community task force that holds regularly scheduled meetings.
Grant Request for Proposal Opioid Abuse Prevention (PDF). If you need this document in another format, please email firstname.lastname@example.org.
Duration of funding
Applicants may apply for the contract period of March 30, 2018 to February 29, 2020.
Approximately $700,000 of state general funds are available for these grants. Up to ten awards may be made, ranging from $50,000 to $150,000. At least one of the awards will be made to one of Minnesota’s Tribal Nations or to an agency or organization serving Minnesota’s urban American Indians.
The estimated project start date is March 30, 2018. The projected end date is February 29, 2020.
Q 1. We are a federally qualified community health center in neighboring state and provide care to Minnesota residents. Based on our clinic location, are we eligible to apply?
A. We believe you are technically eligible to apply for this RFP; however, based on the legislation, bolded some relevant wording that might impact the scoring on the reviews:
Sec. 143. OPIOID ABUSE PREVENTION PILOT PROJECTS (a) The commissioner of health shall establish opioid abuse prevention pilot projects in geographic areas throughout the state based on the most recently available data on opioid overdose and abuse rates, to reduce opioid abuse through the use of controlled substance care teams and community-wide coordination of abuse-prevention initiatives. The commissioner shall award grants to health care providers, health plan companies, local units of government, tribal governments, or other entities to establish pilot projects.
In addition to the above there will be considerable local community level work required as each pilot must, “Engage partners outside of the health care system, including schools, law enforcement, and social services, to address root causes of opioid abuse and addiction at the community level.”
Q 2. Regarding Goal 5 “provide prescriber and dispenser education and assistance to reduce the inappropriate prescribing and dispensing of opioids,” could you provide a definition for “dispenser”? Is this the pharmacist dispensing opioids per the prescription, a caregiver or other individual dispensing opioids directly to the patient, or a different definition?
A. Dispenser is mainly the Pharmacist, but depending on your operation it could include caregiver (but this not the main emphasis). The Pharmacist is the main focus. Yes.
Q 3. Is a hospital and a clinic that is a subsidiary allowed to apply jointly for the Opioid Pilot Project grant?
A. Yes, they can jointly apply.
Q 4. Are Attachments A and B available in Microsoft Word?
A. Access the full Request for Proposals in a Microsoft Word document, including Attachments A and B.
Q 5. Since it will use patient's private health information, should this project be approved by an institution’s IRB?
A. The Project will not require sharing patient's private health information (PHI). As measure of success the sites may be asked to track of the number of patients tapered off or tapered down off narcotics. And the number of pills discontinued. No names or PHI involved
Q 6. Could you explain more about the "Medical home certification"? Is the home care facility able to get certified?
A. There are a number of ways to comply with the “seeking medical home certification” requirement:
- Health Care Home Certification. In Minnesota, our legislature chose to use the term Health Care Homes (HCH) instead of Medical Home or Patient-Centered Medical Home. “The goals of this model is to ensure all Minnesotans have the opportunity to receive team-based, coordinated, patient-centered care; increase care coordination and collaboration between primary care clinicians and community resources to support whole person care and facilitate the broader goals of improving population health and health equity; and improve the quality, experience and value of care.” HCH certification in Minnesota is a free and voluntary program provided to primary care clinics and organizations by the Minnesota Department of Health. HCH certification assures that the team based care delivery approach is a partnership with primary care providers, families and patients.” This is not a certification for home care agencies. Health Care Homes –Certification and Recertification.
- The Joint Commission Primary Care Medical Home designation. The Joint Commission has developed a Primary Care Medical Home option. This option enables the improvements in quality of care and patient safety achieved through accreditation to be combined with the potential for increased reimbursement when the additional requirements of a Primary Medical Home are met. Primary Care Medical Home Certification.
- The National Committee for Quality Assurance (NCQA) has a Patient-Centered Medical Home (PCMH) Recognition program. There is a fee associated with this recognition program. Some Minnesota health systems that have clinics in multiple states have opted to obtain this recognition instead of the Health Care Homes Certification. NCQA Patient-Centered medical Home Recognition.
- NCQA also has an Accountable Care Organization (ACO) Accreditation. There is a fee associated with this Accreditation. The NCQA’s ACO Accreditation program aims to align health plans, employer, and state and federal purchaser expectations to create leverage for prompting organizations to transform how they provide care. ACO accreditation helps determine if an organization has the infrastructure for accountability. NCQA Accountable Care Organization Accreditation. NCQA ACO Accreditation allows for auto-credit for PCMH Recognized Primary Care Providers, and we would encourage you to apply for the auto credit to ensure there is team-based, coordinated, patient-centered care available to patients.
- URAC has a Patient-Centered Medical Home (PCMH) Certification process as well and there is a fee associated with this certification. URAC Patient-Centered Medical Home Certification.
Q 7. Could you explain the "baseline and taper"? Does it indicate the baseline dose of opioid and the taper down dose of opioid after medication assisted treatment (MAT)?
A. As part of measuring outcomes, would expect pilot programs to be able to report the number of patients with chronic opioid prescriptions for baseline data and then the number of patients tapered.
Q 8. Should letters in support of the project, be included with the grant application or as a separate document?
A. Letters of support and be submitted at the same time of the application, but in a separate document.
Q 9. We understand that for both the project goals and project activities section of the grant application, one to three paragraphs should be used to describe each. Is it acceptable to place the one to three paragraphs in bulleted format, to outline the specific goals and activities? Or, are paragraphs the preferred method to define the goals and activities?
A. Either would be fine, as long as the outcome is that we have a clear understanding.
Q 10. Is the budget and budget justification considered a separate attachment or is it part of the 10 page narrative limit? Should we submit a separate work plan or is that also part of the narrative?
A. Budget and budget justification are submitted at the same time as the application but are not part of the 10 page limit.
Q 11. Could you explain more about the "payor mix data"?
A. Broadly we are interested who (i.e. private, Medicaid) is paying for prescriptions, treatment services, etc. and how this may impact outcomes.
Prospective respondents who have any questions regarding this request for proposal must submit all questions in writing at: email@example.com.
In the subject line of the email, include this phrase: Opioid Pilot Project RFP Question All questions received and MDH’s answers to those questions and comments will be posted on this page.
Responses to all questions received by the close of business on Monday, February 19, 2018, will be posted by the close of business, Wednesday, February 21, 2018. Mailed applications are due by 4:30 p.m. on Februrary 26, 2018. Emailed applications may be submitted until 11:59 p.m. on February 26, 2018
Responses to questions received earlier will be posted by the close of each business day.
Other MDH personnel are NOT authorized to discuss this request for proposal with responders before the proposal submission deadline.